CureVac NV (5CV) — Capital Reinvestment Ratio
CureVac NV (5CV) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow (€29.86 Million) in capital expenditures (€322.00K). See CureVac NV (5CV) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
CureVac NV Capital Reinvestment Ratio (2020–2024)
This chart tracks CureVac NV's Capital Reinvestment Ratio across 2 annual periods. Check CureVac NV (5CV) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for CureVac NV (2020–2024)
Year-by-year Capital Reinvestment Ratio for CureVac NV from 2020 to 2024. For live market cap and broader valuation context, see CureVac NV (5CV) total market value.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.18x | €101.85 Million | €18.44 Million | ▲ +160.4% |
| 2020 | 0.07x | €522.40 Million | €36.33 Million | — |